EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A real‐world comparison of celiac tissue transglutaminase immunoglobulin A antibody levels in pediatric patients using two different diagnostic kits

Michal Kori, Anat Guz-Mark, Tsachi Tsadok Perets, Amit Davidpur, Assaf Hoofien iD, Raanan Shamir

JPGN Reports · 09.11.2026

DOI: 10.1002/jpr3.70287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JPGN Reports, online erschienen am 09.11.2026. Verfasst von Michal Kori und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Gastroenterology Kaplan Medical Center Rehovot Israel. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Pediatric celiac disease (CeD) may be diagnosed without a biopsy when tissue‐transglutaminase (TTG) immunoglobulin A (IgA) antibodies are ≥10x the upper limit of normal (ULN) and anti‐endomysial antibodies are positive in a second sample. The no‐biopsy diagnosis demands a very high accuracy and reliability of the TTG diagnostic kits. Inter‐assay differences may affect category classification. We compared TTG‐IgA levels performed by two reliable kits: Bioplex 2200 and Liaison‐XL in routine care.

Methods

Using the Clalit Health Services database, we identified pediatric patients with paired TTG‐IgA measurements from both kits within ≤14 days. Values were expressed as multiples of ULN and categorized: 10x ULN. Agreement was assessed for ≤7 and ≤14‐day windows using Cohen's ĸ .

Results

Category discordance occurred in 17.4% (109/625) of paired tests within 14 days and 11.8% (38/321) within 7 days. Overall agreement was substantial ( ĸ = 0.62 for 14 days; ĸ = 0.63 for 7 days). Concordance was high for negative results (96.0%), but significantly lower for the critical >10x ULN threshold at 14 days (88.2%, p = 0.009).

Conclusions

Significant discordance between these two reliable TTG‐IgA kits at 14 days, exceeding 10% in the >10x ULN category, warrants careful consideration when using the no‐biopsy approach for CeD diagnosis, as assay choice may impact clinical classification.

Schlagwörter

Stichwörter der Autor:innen

Inter‐assay discordanceNo‐biopsy approachguidelines

Autor:innen und Institutionen

  • Pediatric Gastroenterology Kaplan Medical Center Rehovot Israel.
  • Faculty of Medicine Hebrew University of Jerusalem Jerusalem Israel.
  • Institute of Gastroenterology, Nutrition and Liver Diseases Schneider Children's Medical Center of Israel Petach Tikva Israel.
  • Gray Faculty of Medical and Health Sciences Tel-Aviv University Tel Aviv Israel.
  • Gastroenterology Laboratory, Rabin Medical Center Petach Tikva Israel.
  • Department of Digital Medical technologies Holon Institute of Technology Holon Israel.

ORCID-Profile: Assaf Hoofien

Zitieren

APA

Kori, M., Guz-Mark, A., Perets, T. T., Davidpur, A., Hoofien, A., & Shamir, R. (2026). A real‐world comparison of celiac tissue transglutaminase immunoglobulin A antibody levels in pediatric patients using two different diagnostic kits. JPGN Reports. https://doi.org/10.1002/jpr3.70287

Vancouver

Kori M, Guz-Mark A, Perets TT, Davidpur A, Hoofien A, Shamir R. A real‐world comparison of celiac tissue transglutaminase immunoglobulin A antibody levels in pediatric patients using two different diagnostic kits. JPGN Reports. 2026. doi:10.1002/jpr3.70287

BibTeX
@article{Kori2026,
  author = {Kori, Michal and Guz-Mark, Anat and Perets, Tsachi Tsadok and Davidpur, Amit and Hoofien, Assaf and Shamir, Raanan},
  title = {A real‐world comparison of celiac tissue transglutaminase immunoglobulin A antibody levels in pediatric patients using two different diagnostic kits},
  journal = {JPGN Reports},
  year = {2026},
  doi = {10.1002/jpr3.70287}
}
Kostenlos starten →